The Modulating Effects of Resveratrol on the Expression of Mmp-2 and Mmp-9 in Endometriosis Women: A Randomized Exploratory Trial Publisher Pubmed



Kodarahmian M¹ ; Amidi F^{1, 2} ; Moini A³ ; Kashani L³ ; Shabani Nashtaei M^{1, 2} ; Pazhohan A^{4, 5} ; Bahramrezai M¹ ; Berenjian S¹ ; Sobhani A¹ Show Affiliations
Source: Gynecological Endocrinology Published:2019

Abstract

Endometriosis is an inflammatory disease; the hallmark of inflammation is over-activation of matrix metalloproteinases (MMPs). The regulatory effects of Resveratrol on MMPs were formerly depicted in other cell lines. This study aimed at investigating the effects of Resveratrol on expression of MMP-2 and -9 in endometriosis patients. This trial was carried out on endometriosis patients (n = 34) who were randomly divided into treatment (i = 17) and control (n = 17) groups. Alongside the routine protocol, the control and treatment groups took placebo and Resveratrol (400 mg), respectively, for 12–14 weeks. Endometrial tissue and fluid as well as blood sampling from both groups were done before and after the intervention. The level of mRNA and protein of both MMP-2 and -9 reduced in the endometrium of treatment group following intervention. Also, the serum and the endometrial fluid concentration of them lowered within the treatment group. Moreover, the serum and endometrial fluid levels of MMP-2 as well as MMP-9 were also diminished following the surgical removal of endometritic lesions. We showed that Resveratrol can modify the inflammation process in the endometrium of women with endometriosis at least in the level of MMP-2 and -9 expressions. The therapeutic potency of Resveratrol in endometriosis needs more clinical studies. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.